300 results on '"Sorce, Gabriele"'
Search Results
2. Does previous transurethral resection of the prostate affect the outcomes in robotic assisted radical prostatectomy?
3. Transitioning from Da Vinci Si to Xi: assessing surgical outcomes at a high-volume robotic center
4. In-Hospital Venous Thromboembolism and Pulmonary Embolism After Major Urologic Cancer Surgery
5. Impact of prostate MRI central review over the diagnostic performance of MRI-targeted biopsy: should we routinely ask for an expert second opinion?
6. Evaluation of Clinical Research on Novel Multiport Robotic Platforms for Urological Surgery According to the IDEAL Framework: A Systematic Review of the Literature
7. Robot-assisted Radical Prostatectomy Performed with Different Robotic Platforms: First Comparative Evidence Between Da Vinci and HUGO Robot-assisted Surgery Robots
8. ASO Visual Abstract: In-Hospital Venous Thromboembolism and Pulmonary Embolism After Major Urological Cancer Surgery
9. Contemporary vs historical survival rates in metastatic clear cell renal carcinoma according to race/ethnicity
10. Regional differences in total hospital costs for radical cystectomy in the United States
11. Mortality According to Treatment in Metastatic Collecting Duct Renal Cell Carcinoma
12. Cancer specific mortality in patients with collecting duct vs. clear cell renal carcinoma
13. Adverse upgrading and/or upstaging in contemporary low-risk prostate cancer patients
14. Added Value of Prostate-specific Antigen Density in Selecting Prostate Biopsy Candidates Among Men with Elevated Prostate-specific Antigen and PI-RADS ≥3 Lesions on Multiparametric Magnetic Resonance Imaging of the Prostate: A Systematic Assessment by PI-RADS Score
15. Cancer-specific Mortality in T1a Renal Cell Carcinoma Treated with Local Tumor Destruction Versus Partial Nephrectomy
16. MP19-07 TOWARDS A TAILORED USE OF PSA DENSITY TO DECIDE WHEN TO AVOID PROSTATE BIOPSY IN MEN WITH PIRADS 3 LESIONS ACCORDING TO THE LOCATION OF THE INDEX LESION AT MP-MRI. RESULTS OF A LARGE, MULTI-INSTITUTIONAL SERIES
17. PD50-09 A NOMOGRAM TO PREDICT LYMPHNODE INVOLVEMENT IN CANDIDATES TO ROBOT-ASSISTED RADICAL PROSTATECTOMY WITH IT3 PROSTATE CANCER ON PREOPERATIVE MULTIPARAMETRIC MRI AS UNIQUE HIGH-RISK FEATURE
18. PD45-05 WHEN DOES SYSTEMATIC BIOPSY INFORMATION MATTER THE MOST? IDENTIFYING INDEPENDENT PREDICTORS OF DISEASE DOWNGRADING AT RADICAL PROSTATECTOMY IN HIGH GRADE PROSTATE CANCER BASED ON A LARGE MULTI-INSTITUTIONAL SERIES
19. PD09-03 ASSESSING EPIGENETIC FEATURES ASSOCIATED WITH LYMPH NODE METASTASES IN PROSTATE CANCER
20. MP73-11 TRAIN THE TRAINERS FOR THE DELIVERY OF PROFICIENCY BASED PROGRESSION TRAINING BY THE EUROPEAN ROBOTIC SURGICAL SECTION FELLOWSHIP CENTERS
21. MP37-20 THE EFFECT OF PENILE REHABILITATION AFTER ROBOT-ASSISTED RADICAL PROSTATECTOMY ON URINARY CONTINENCE AND ERECTILE FUNCTION RECOVERY. RESULTS FROM a HIGH-VOLUME, SINGLE-SURGEON SERIES
22. Life expectancy in metastatic urothelial bladder cancer patients according to race/ethnicity
23. Plasmacytoid variant urothelial carcinoma of the bladder: effect of radical cystectomy and chemotherapy in non-metastatic and metastatic patients
24. Effect of Inferior Vena Cava Tumor Thrombus on Overall Survival in Metastatic Renal Cell Carcinoma Patients Treated with Cytoreductive Nephrectomy
25. Contemporary Pathological Stage Distribution After Radical Prostatectomy in North American High-Risk Prostate Cancer Patients
26. The effect of frailty on post-operative outcomes and health care expenditures in patients treated with partial nephrectomy
27. Metastatic stage vs complications at radical nephrectomy with inferior vena cava thrombectomy
28. Standardising the Assessment of Patient-reported Outcome Measures in Localised Prostate Cancer. A Systematic Review
29. Up- and downgrading in single intermediate-risk positive biopsy core prostate cancer
30. Cancer-specific mortality after radical prostatectomy vs external beam radiotherapy in high-risk Hispanic/Latino prostate cancer patients
31. Survival after radical prostatectomy vs. radiation therapy in ductal carcinoma of the prostate
32. Optimizing prostate-targeted biopsy schemes in men with multiple mpMRI visible lesions: should we target all suspicious areas? Results of a two institution series
33. Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis
34. Impact of the time elapsed between prostate biopsy and surgery on the accuracy of nomograms predicting lymph node invasion in patients with clinically localized prostate cancer
35. The association of type and number of high-risk criteria with cancer-specific mortality in prostate cancer patients treated with radical prostatectomy.
36. Variability of mpMRI diagnostic performance according to the upfront individual patient risk of having clinically significant prostate cancer
37. Variability of mpMRI diagnostic performance according to the upfront individual patient risk of having clinically significant prostate cancer.
38. Urological surgery with the Hugo RAS™ System: insights into system adaptability.
39. Robot-Assisted Pyeloplasty with HUGO™ Robotic System: Initial Experience and Optimal Surgical Set-Up at a Tertiary Referral Robotic Center.
40. A comparative analysis of the HUGOTM robot‐assisted surgery system and the Da Vinci® Xi surgical system for robot‐assisted sacrocolpopexy for pelvic organ prolapse treatment.
41. Re: Unilateral Pelvic Lymph Node Dissection in Prostate Cancer Patients Diagnosed in the Era of Magnetic Resonance Imaging-targeted Biopsy: A Study that Challenges the Dogma
42. Initial Experience of Robot-Assisted Simple Prostatectomy with Hugo Robot-Assisted Surgery System: Step-by-Step Description of Two Different Techniques
43. Radical Cystectomy vs. Radiotherapy in Urothelial Bladder Cancer in Elderly and Very Elderly Patients
44. PD10-09 A NOVEL MODEL INTEGRATING CLINICAL, MP-MRI, AND EPIGENOMIC FEATURES TO PREDICT LYMPH NODE INVASION IN PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY AND PELVIC LYMPH NODE DISSECTION
45. MP40-14 ARE EAU RISK GROUPS RELIABLE IN THE STRATIFICATION OF MEN WITH BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY AND RESTAGED WITH PSMA-PET?
46. MP40-07 HAS THE INTRODUCTION OF MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING OF THE PROSTATE AND TARGETED BIOPSIES LED TO A RISK OF OVERGRADING OF HIGH RISK PROSTATE CANCER? RESULTS FROM A CONTEMPORARY LARGE MULTI-INSTITUTIONAL SERIES.
47. MP11-11 TAILORING THE OPTIMAL USE OF ANDROGEN-DEPRIVATION THERAPY CONCOMITANT TO POST-OPERATIVE RADIOTHERAPY AMONG MEN WITH PN1 PROSTATE CANCER. LONG-TERM RESULTS OF A LARGE, SINGLE INSTITUTION SERIES
48. PD39-10 THE ASSOCIATION BETWEEN PSA DENSITY AND THE DETECTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER ACROSS ALL PIRADS SCORES IN MEN WITH POSITIVE MPMRI. WHEN PSA DENSITY CAN HELP AVOIDING PROSTATE BIOPSY?
49. MP38-11 IS THERE AN IMPACT OF THE CENTER PERFORMING BASELINE MULTIPARAMETRIC MRI ON ACTIVE SURVEILLANCE OUTCOMES IN PROSTATE CANCER PATIENTS?
50. MP67-04 VALIDATION OF NOVEL PREOPERATIVE RISK CATEGORIES ON THE PREDICTION OF CLINICAL RECURRENCE IN PATIENTS CANDIDATE FOR RADICAL PROSTATECTOMY FOR CLINICALLY LOCALIZED PROSTATE CANCER. RESULTS OF A LARGE, MULTI-INSTITUTIONAL SERIES
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.